摘要
Abstract
Objective To comparatively observe the clinical effect of Etanecept and Common drugs on Ankylosing Spondylitis(AS), and to analyze the clinical application value and safety. Methods 34 cases of AS patients who were admitted into our hospital from Dec. 2011 to Dec. 2012 were selected as the research subject and divided into test group and control group randomly, the control group was treated with general therapy, while the test group treated with Etanercept in addition to general therapy. The clinical effect and adverse reaction were comparatively studied. Results The NASDAI, BASFI scores, morning stiffness time, night back pain VAS, total back pain VAS, erythrocyte sedimentation rate, C-reactive protein value of within two groups before and after treatment had no statistical difference (P>0.05), while the value of each indicator after the treatment had a statistical difference (P<0.05). The complications occurrence rate of two groups has astatistical difference(P < 0.05). Conclusion Etanercept has an obvious effect on AS, and has a less complication rate and high safety.关键词
依那西普/强直性脊柱炎/临床疗效/安全性Key words
Etanercept/Ankylosing spondylitis/Clinical effect/Safety分类
医药卫生
